Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676626

Cover Image

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676626

Orthopedic Cell Therapy Market Size, Share, and Trend Analysis | Global | 2025-2031 | MedCore | Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market

PUBLISHED:
PAGES: 75 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 6995
PDF (Corporate License)
USD 8995

Add to Cart

The global orthopedic cell therapy market was valued at $551.3 million in 2024 and is projected to grow at a CAGR of 7.2%, reaching $895.8 million by 2031.

This market includes two primary therapy types:

  • Platelet-Rich Cell Therapy
  • Bone Marrow Cell Therapy
  • Market Insights & Data Coverage
  • Unit Sales & Average Selling Prices
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Historical Data (2021-2023)
  • Competitive Landscape, Mergers & Acquisitions
  • Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

  • The COVID-19 pandemic caused a temporary decline in sales due to the postponement of elective procedures.

* By 2022, the market rebounded, returning to a trajectory of steady growth.

* Advancements in Cell Therapy Technology:

  • Growth in regenerative medicine is driving demand for platelet-rich plasma (PRP) and bone marrow aspirate (BMA) therapies.

* Improved processing systems are enhancing the efficacy and adoption of orthopedic cell therapies.

  • Increased Adoption in Orthopedics & Sports Medicine:

* Rising demand for minimally invasive treatments is fueling the market.

* Soft tissue injuries, joint reconstructions, and spine treatments are key growth areas.

Market Share Insights

Top Competitors in the Global Orthopedic Cell Therapy Market (2024):

1 Terumo

* Market leader with its Harvest Technologies division.

* Offers Harvest(R) BMAC, Harvest(R) PRP, and the Harvest(R) AdiPrep(R) adipose tissue concentrator.

* The Harvest(R) SmartPrep system enables multicellular processing for bone marrow, blood, and adipose tissue.

2 Zimmer Biomet

* Second-largest market share with its Plasmax(R) Plasma concentration system and BioCUE(TM) System.

* BioCUE(TM) System processes both bone marrow and whole blood for cell therapy applications.

3 Arthrex

* Third-largest competitor, known for its Angel(R) cPRP and Bone Marrow Processing System.

* The Angel(R) System automates the separation and concentration of PRP and BMA for orthopedic and soft tissue applications.

Market Segmentation Summary

  • Platelet-Rich Cell Therapy Market

* Indications: Soft Tissue, Spine, Cardiac, Orthopedic, Plastics.

  • Bone Marrow Cell Therapy Market

* Indications: Soft Tissue, Spine, Trauma, Joint Reconstructions.

Global Research Scope

  • Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage

  • Market Size, Market Shares
  • Market Forecasts, Growth Rates
  • Units Sold, Average Selling Prices
  • Procedure Numbers

Qualitative Coverage

  • COVID-19 Impact
  • Market Growth Trends & Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles & Product Portfolios
  • FDA Recalls, Disruptive Technologies
  • Disease Overviews

Data Sources:

  • Primary Interviews with Industry Leaders
  • Government Physician Data & Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database
Product Code: iDATA_GLOB25_MC_OCT

TABLE OF CONTENT

  • 6.1 EXECUTIVE SUMMARY
    • 6.1.1 Global Orthopedic Cell Therapy Market Overview
    • 6.1.2 Competitive Analysis
    • 6.1.3 Procedure Segmentation
    • 6.1.4 Market Segmentation
    • 6.1.5 Regions Included
  • 6.2 INTRODUCTION
    • 6.2.1 Platelet-Rich Plasma
    • 6.2.2 Concentrated Bone Marrow Aspirate
  • 6.3 PROCEDURE NUMBERS
    • 6.3.1 Total Orthopedic Cell Therapy Procedures
    • 6.3.2 Platelet-Rich Plasma Procedures
    • 6.3.3 Bone Marrow Aspirate Concentrate Procedures
  • 6.4 MARKET OVERVIEW
    • 6.4.1 By Segment
    • 6.4.2 By Region
  • 6.5 MARKET ANALYSIS AND FORECAST
    • 6.5.1 Platelet-Rich Plasma Market
    • 6.5.2 Bone Marrow Aspirate Concentrate Market
  • 6.6 UNIT ANALYSIS
    • 6.6.1 Platelet-Rich Plasma Unit Analysis
      • 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
    • 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
      • 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
  • 6.7 DRIVERS AND LIMITERS
    • 6.7.1 Market Drivers
    • 6.7.2 Market Limiters
  • 6.8 COMPETITIVE MARKET SHARE ANALYSIS
Product Code: iDATA_GLOB25_MC_OCT

LIST OF CHARTS

  • Chart 6 1: Orthopedic Cell Therapy Market, Global, 2024 & 2031
  • Chart 6 2: Orthopedic Cell Therapy Procedures, Global, 2024
  • Chart 6 3: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Chart 6 4: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031
  • Chart 6 5: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031
  • Chart 6 6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024

LIST OF FIGURES

  • Figure 6 1: Orthopedic Cell Therapy Procedure Segmentation
  • Figure 6 2: Orthopedic Cell Therapy Market Segmentation
  • Figure 6 3: Orthopedic Cell Therapy Regions Covered, Global (1 of 2)
  • Figure 6 4: Orthopedic Cell Therapy Regions Covered, Global (2 of 2)
  • Figure 6 5: Orthopedic Cell Therapy Procedures by Segment, Global, 2021 - 2031
  • Figure 6 6: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Figure 6 7: Orthopedic Cell Therapy Procedures by Country, North America, 2021- 2031
  • Figure 6 8: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 9: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 10: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 11: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 12: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 13: Orthopedic Cell Therapy Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 14: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 15: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 16: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 17: Orthopedic Cell Therapy Procedures by Country, Africa, 2021 - 2031
  • Figure 6 18: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2021 - 2031
  • Figure 6 19: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2021 - 2031
  • Figure 6 20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 26: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 27: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 28: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 29: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2021 - 2031
  • Figure 6 30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2021 - 2031
  • Figure 6 31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2021 - 2031
  • Figure 6 32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6 33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6 34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6 35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6 36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6 37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2021 - 2031
  • Figure 6 38: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6 39: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6 40: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6 41: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2021 - 2031
  • Figure 6 42: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 6 43: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 6 44: Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6 45: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6 46: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$)
  • Figure 6 47: Market Value by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$M)
  • Figure 6 48: Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6 49: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6 50: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$)
  • Figure 6 51: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$M)
  • Figure 6 52: Platelet-Rich Plasma Units Sold by Indication, Global, 2021 - 2031
  • Figure 6 53: Bone Marrow Aspirate Concentrate Units Sold by Indication, Global, 2021 - 2031
  • Figure 6 54: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!